This compound is a sulfamoyl-substituted pyrimidine derivative featuring bromophenyl and chloropyrimidinyl ether moieties. It is primarily utilized as a pharmaceutical intermediate in the synthesis of research compounds related to Macitentan analogs.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2443747-63-3
Macitentan
pharmaceutical raw material
Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-(4-chlorophenyl)-4-pyrimidinyl]-N'-propyl-
pharmaceutical raw material
Macitentan metabolite M4
pharmaceutical raw material
Benzyl (2S)-2-amino-6-(phenylmethoxycarbonylamino)hexanoate
pharmaceutical intermediate
4-Phenyl-1-(p-tolylsulphonyl)piperidine-4-carbonitrile
pharmaceutical intermediate
2-[(tert-Butoxycarbonyl)amino]-5-hydroxybenzoic acid
pharmaceutical intermediate
4-[(4-Chloro-2-pyrimidinyl)amino]benzonitrile
pharmaceutical intermediate
Aprocitentan
pharmaceutical raw material
5-(4-bromophenyl)-6-[2-(5-chloropyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine
ZAECTGVKYBAJMM-UHFFFAOYSA-N
CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Cl)C3=CC=C(C=C3)Br